Evidence map›Paper›PMID 40333262›Full record

ArticleVaccines2025

Estimating the Public Health and Economic Impact of Annual mRNA COVID-19 Vaccination for Adults Aged 50 and Older in South Korea's Endemic Era.

Jaehee Jung, Dain Lee, Hee-Do Yang, Ah-Young Kim, Haeun Lee, Minkyoung Kang, Ekkehard Beck, Keya Joshi, Youngju Kang, Hye-Young Kang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jaehee JungYonsei Institute of Pharmaceutical Science, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.ORCID 0009-0009-0985-2457
Dain LeeYonsei Institute of Pharmaceutical Science, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Hee-Do YangGraduate Program of Industrial Pharmaceutical Science, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Ah-Young KimCollege of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.ORCID 0000-0001-7264-7602
Haeun LeeGraduate Program of Industrial Pharmaceutical Science, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Minkyoung KangYonsei Institute of Pharmaceutical Science, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Ekkehard BeckModerna, Inc., 325 Binney St, Cambridge, MA 02142, USA.ORCID 0000-0002-2022-9190
Keya JoshiModerna, Inc., 325 Binney St, Cambridge, MA 02142, USA.
Youngju KangModerna Korea, Seoul 03185, Republic of Korea.
Hye-Young KangYonsei Institute of Pharmaceutical Science, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.

Funding

Moderna Korea Limited No specific grant number is provided
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

annual vaccinationcostsCOVID-19hospitalizationpreventionvaccine effectivenessvaccine uptake

Identifiers

PMID40333262
PMCPMC12031038

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.